Aoruibio
Aoruibio, operating under the brand AULBIO, is a South Korean biotechnology company focused on innovative microsphere drug delivery technology called EXTENNA. It provides platform services for long‑acting therapeutics, partnering with pharmaceutical firms to develop injectable, long‑acting products. The company emphasizes smart manufacturing systems, R&D pipelines, and global collaborations to advance bio‑healthcare solutions.
Aoruibio is listed with 1 API on the APIs.io network. Tagged areas include Biotechnology, Healthcare, Drug Delivery, Platform, and South Korea.
Aoruibio’s developer surface includes documentation and 9 more developer resources.
Kin Score
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
AULBIO API
API documentation for AULBIO platform services.
Terms of Service 1
What its API terms permit and prohibit, quoted from its own page.
Privacy & Data 1
Its role, the data it processes, retention and transfers, quoted from its own privacy page.
Eligibility 1
Who may sign up and where, quoted from its own terms.
Data License 1
How its data and outputs may be reused, quoted from its own terms.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Commercial 4
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Aoruibio API — frequently asked questions
Does Aoruibio have an API?
Yes. APIs.io lists 1 API from Aoruibio, including AULBIO API.
Is the Aoruibio API ready for AI agents?
Aoruibio has a Kin Score of 12.7 out of 100 (emerging) and an Agent Readiness score of 0.0 (human-only), scored by API Evangelist on 2026-11-13.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.